Fortress Biotech (NASDAQ: FBIO)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-14 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.100 | 0.1100 | ||||
REV | 23.180M | 18.886M | -4.294M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Fortress Biotech (NASDAQ: FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and Infinity Pharmaceuticals (NASDAQ:INFI).
The latest price target for Fortress Biotech (NASDAQ: FBIO) was reported by Ladenburg Thalmann on Thursday, August 4, 2022. The analyst firm set a price target for 6.00 expecting FBIO to rise to within 12 months (a possible 412.82% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $1.17 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech’s Q3 earnings are confirmed for Monday, November 14, 2022.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.